Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 63

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 63
---
 time either the persons
who will receive such awards under the Amended Incentive Plan or the amount or types of any such awards.

The fair market value of our Common
Stock is approximately $1.29 per share based on the closing price of our Common Stock on October 3, 2025.

Required Vote

The affirmative vote of one third
of the votes cast in person or represented by proxy at the meeting and entitled to vote for
this proposal is required to approve the proposed amendments to the Renovaro Biosciences, Inc. 2023 Equity Incentive Plan.

OUR BOARD RECOMMENDS A VOTE TO APPROVE THE PROPOSED AMENDMENTS TO THE 2023 RENOVARO BIOSCIENCES, INC. 2023 EQUITY INCENTIVE PLAN, AND PROXIES SOLICITED BY OUR BOARD WILL BE VOTED IN FAVOR OF THE AMENDMENTS UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY.

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following
sets forth information regarding the beneficial ownership of our common stock as of October 3, 2025 by:

| ● | each person to be known by us to be the beneficial owner of more than 5% of our common stock; |

| ● | each of our named executive officers; |

| ● | each of our directors; and |

| ● | all of our current executive officers and directors as a group. |

Beneficial
ownership of the Common Stock is determined in accordance with the rules of the SEC and includes any shares of Common Stock over which
a person exercises sole or shared voting or investment power, or of which a person has a right to acquire ownership at any time within
60 days. Except as otherwise indicated, we believe that the persons named in this table have sole voting and investment power with respect
to all shares of Common Stock held by them. Applicable percentage ownership in the following table is based on 23,178,153 shares of Common
Stock outstanding as of October 3, 2025, excluding 894,056 shares of Common Stock issuable only upon the exercise of warrants by other
warrant holders plus any securities that the individuals included in this table have the right to acquire within 60 days of October 3,
2025.

Of the
total 894,056 shares of Common Stock issuable only upon the exercise of warrants by other